Summary
The ubiquitin-proteasome proteolytic pathway is involved in an important non-lysosomal proteolytic pathway that is responsible for the highly selective turnover of cellular proteins both under basal metabolic conditions as well as stress. Protein degradation by this pathway is attributed to the 20S proteasome that forms the catalytic core of the complex. Recently there has been increasing interest in the proteasome because of its possible role in neuron degeneration and death. Fetal Down syndrome (DS) neurons were demonstrated to degenerate and undergo apoptosis in vitro. We therefore investigated the expression of different proteins involved in this degradative pathway, including subunits of the 20S proteasome, ubiquitinating and deubiquitinating enzymes, and regulatory subunits of the 26S proteasome in control and DS fetal brains by two-dimensional electrophoresis (2-DE). After 2-DE, approximately 389 protein spots were successfully identified by matrix-associated laser desorption ionization mass spectroscopy (MALDI-MS) and this was followed by quantification of twenty three proteins of the pathway. The results indicate that all but two proteins exhibited no apparent alterations in their pattern of expression. Proteasome zeta chain, an alpha subunit of the 20S proteasome (P < 0.05) and ubiquitin carboxy-terminal hydrolase T (Isopeptidase T), a deubiquitinating enzyme (P < 0.001) were significantly increased in fetal DS compared to controls. Whilst the expression of proteasome iota (n = 9, r = -0.9489, P = 0.0004) and proteasome epsilon (n = 9, r = -0.7227, P = 0.0311) chains was decreased with age in fetal DS brain, no significant correlation was obtained in the other proteins with age. The data suggest that such selective upregulation may have relevance to the developmental abnormalities that characterize this disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahn JY, Hong SO, Kwak KB, Kang SS, Tanaka K, Ichihara A, Ha DB, Chung CH (1991) Developmental regulation of proteolytic activities and subunit pattern of 20S proteasome in chick embryo muscle. J Biol Chem 266: 15746–15749
Amerik A Yu, Swaminathan S, Krantz BA, Wilkinson KD, Hochstrasser M (1997) In vivo disassembly of free polyubiquitin chains by yeast Ubp 14 modulates rates of protein degradation by the proteasome. EMBO J 16: 4826–4838
An WG, Hwang SG, Trepel JB, Blagosklonny MV (2000) Protease inhibitor induced apoptosis: accumulation of p53, p21/WAF-l/CIPl and induction of apoptosis are independent marker of proteasome inhibition. Leukemia 14: 1276–1283
Berndt P, Hobohm U, Langen H (1999) Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20: 3521–3526
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378: 776–779
Castagne V, Gautschi M, Lefevre K, Posada A, Clarke PG (1999) Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog Neurobiol 59: 397–423
Ciechanover A (1994) The ubiquitin-proteasome proteolytic pathway. Cell 79: 13–21
Ciechanover A, Schwartz AL (1994) The ubiquitin mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J 8: 182–191
Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65: 801–847
DeMartino GN, Orth K, McCullough ML, Lee LW, Munn TZ, Moomaw CR, Dawson PA, Slaughter CA (1991) The primary structures of four subunits of the human high molecular weight proteinase, macropain (proteasome) are distinct but homologous. Biochim Biophys Acta 1079: 29–38
Epstein CJ (1995) Down Syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn, vol 1. McGraw Hill, New York, pp 749–794
Fountoulakis M, Langen H (1997) Identification of proteins by matrix assisted laser desorption ionization mass spectrometry following in-gel digestion in low salt, non-volatile buffer and simplified peptide recovery. Anal Biochem 250: 153–156
Früh K, Gossen M, Wang K, Bujard H, Peterson PA, Yang Y (1994) Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J 13: 3236–3244
Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R (1997) Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 386: 463–471
Hadari T, Warms JV, Rose IA, Hershko A (1992) A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation. J Biol Chem 267: 719–727
Hilt W, Wolf DH (1996) Proteasomes: destruction as a program. Trends Biochem Sci 2: 96–102
Hochstrasser M (1995) Ubiquitin, proteasomes and the regulation of intracellular protein degradation. Curr Opin Cell Biol 7: 215–223
Hochstrasser M (1996) Ubiquitin dependent protein degradation. Ann Rev Genet 30: 405–439
Jentsch S, Schlenker S (1995) Selective protein degradation: a journey’s end within the proteasome. Cell 82: 881–884
Keller JN, Hanni KB, Markesbery WR (2000a) Impaired proteasome function in Alzheimer’s disease. J Neurochem 75: 436–439
Keller JN, Huang FF, Markesbery WR (2000b) Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neurosci 98: 149–156
Kumatori A, Tanaka K, Inamura N, Sone S, Ogura T, Matsumoto T, Tachikawa T, Shin S, Ichihara A (1990) Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci USA 87: 7071–7075
Langen H, Röder D, Juranville JF, Fountoulakis M (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two dimensional gel electrophoresis. Electrophoresis 18: 2085–2090
Larsen CN, Krantz BA, Wilkinson KD (1998) Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37: 3358–3368
Leroy E, Boyer R, Auberger G, Leube B, Ulm G, Mezey E, et al (1998) The ubiquitin pathway in Parkinson’s disease. Nature 395: 451–452
McNaught KStP, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson’s disease. Neurosci Lett 297: 191–194
Moazed D, Johnson AD (1996) A deubiquitinating enzyme interacts with SIR4 and regulates silencing in S. cerevisiae. Cell 86: 667–677
Murakami Y, Matsufuji S, Kameji T, Hayashi S, Igarashi K, Tamura T, Tanaka K, Ichihara A (1992) Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360: 597–599
Naviglio S, Matteucci C, Matoskova B, Nagase T, Nomura N, Di Fiore PP, Draetta GF (1998) UBP Y: a growth regulated human ubiquitin isopeptidase. EMBO J 17: 3241–3250
Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K (1999) 4-OH-2-nonenal mediated impairment of intracellular proteolysis during oxidative stress. J Biol Chem 274: 23787–23793
Peters JM (1994) Proteasomes: protein degradation machines of the cell. Trends Biochem Sci 19: 377–382
Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJA, Grune T (1998) Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335: 637–642
Reinheckel T, Ullrich O, Sitte N, Grune T (2000) Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys 377: 65–68
Rivett AJ (1998) Intracellular distribution of proteasomes. Curr Opin Immunol 10:110–114
Shapiro BL (1999) The Down syndrome critical region. J Neural Transm 57: 41–60
Wilkinson KD, Tashayev VL, O’Connor LB, Larsen CL, Kasperek E, Pickart CM (1995) Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T. Biochemistry 34: 14535–14546
Zhu Y, Carrol M, Papa FR, Hochstrasser M, D’Andrea AD (1996) DUB-1, a deubiquitinating enzyme with growth suppressing activity. Proc Natl Acad Sci USA 93: 3275–3279
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag/Wien
About this chapter
Cite this chapter
Engidawork, E., Juranville, JF., Fountoulakis, M., Dierssen, M., Lubec, G. (2001). Selective upregulation of the ubiquitin-proteasome proteolytic pathway proteins, proteasome zeta chain and isopeptidase T in fetal Down syndrome. In: Lubec, G. (eds) Protein Expression in Down Syndrome Brain. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6262-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6262-0_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83704-7
Online ISBN: 978-3-7091-6262-0
eBook Packages: Springer Book Archive